Companies / ELI LILLY & Co / Activity
Activity — ELI LILLY & Co
107 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $45.19M | -41K -0.04% | 92,023,036 9.78% of shares | high |
| Feb 9, 2026 | Ricks David A CEO | Grant | Common Stock | $40.65M | +39K +7.30% | 571,715 0.06% of shares | low |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $37.96M | -34K -0.04% | 92,063,992 9.78% of shares | high |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $26.93M | -24K -0.03% | 91,977,632 9.77% of shares | high |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $23.24M | -21K -0.02% | 92,001,994 9.77% of shares | high |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $22.76M | -21K -0.02% | 92,098,426 9.78% of shares | high |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $22.48M | -20K -0.02% | 92,134,031 9.79% of shares | high |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $18.44M | -17K -0.02% | 91,947,281 9.77% of shares | high |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $16.44M | -15K -0.02% | 92,119,094 9.79% of shares | high |
| Feb 9, 2026 | Skovronsky Daniel Executive | Grant | Common Stock | $16.24M | +16K +10.76% | 160,072 0.02% of shares | low |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $15.16M | -14K -0.01% | 91,963,931 9.77% of shares | high |
| Feb 1, 2026 | Ricks David A CEO | Other | Common Stock | $14.83M | -14K -2.61% | 532,802 0.06% of shares | low |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $14.68M | -13K -0.01% | 91,934,034 9.77% of shares | high |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $10.52M | -10K -0.01% | 92,154,478 9.79% of shares | medium |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $10.08M | -9K -0.01% | 91,906,267 9.76% of shares | medium |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $9.44M | -9K -0.01% | 91,925,521 9.77% of shares | medium |
| Feb 9, 2026 | Hakim Anat Executive | Grant | Common Stock | $8.65M | +8K +56.28% | 22,987 <0.01% of shares | low |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $8.35M | -8K -0.01% | 92,180,547 9.79% of shares | medium |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $7.03M | -6K -0.01% | 92,164,051 9.79% of shares | medium |
| Feb 1, 2026 | Skovronsky Daniel Executive | Other | Common Stock | $5.85M | -6K -3.76% | 144,524 0.02% of shares | low |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $5.18M | -5K -0.01% | 91,915,320 9.76% of shares | medium |
| Feb 9, 2026 | Van Naarden Jacob Executive | Grant | Common Stock | $5.08M | +5K +22.36% | 26,626 <0.01% of shares | low |
| Feb 9, 2026 | Jonsson Patrik Executive | Grant | Common Stock | $5.03M | +5K +8.63% | 60,647 <0.01% of shares | low |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $4.84M | -4K -0.00% | 91,901,925 9.76% of shares | medium |
| Feb 9, 2026 | Rau Diogo Executive | Grant | Common Stock | $4.80M | +5K +21.10% | 26,397 <0.01% of shares | low |
| Feb 9, 2026 | Rau Diogo Executive | Grant | Common Stock | $4.63M | +4K +20.33% | 26,230 <0.01% of shares | low |
| Feb 9, 2026 | Hernandez Edgardo Executive | Grant | Common Stock | $4.58M | +4K +10.51% | 46,096 <0.01% of shares | low |
| Feb 9, 2026 | Yuffa Ilya Executive | Grant | Common Stock | $4.35M | +4K +14.79% | 32,304 <0.01% of shares | low |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $3.90M | -4K -0.00% | 92,174,972 9.79% of shares | medium |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $3.85M | -3K -0.00% | 91,922,057 9.76% of shares | medium |
| Feb 9, 2026 | Dozier Eric Executive | Grant | Common Stock | $3.67M | +4K +30.75% | 14,936 <0.01% of shares | low |
| Feb 1, 2026 | Hakim Anat Executive | Other | Common Stock | $3.06M | -3K -16.72% | 14,709 <0.01% of shares | low |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $3.06M | -3K -0.00% | 91,896,978 9.76% of shares | medium |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $2.47M | -2K -0.00% | 91,899,715 9.76% of shares | medium |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $2.32M | -2K -0.00% | 91,919,972 9.76% of shares | medium |
| Feb 1, 2026 | Van Naarden Jacob Executive | Other | Common Stock | $1.98M | -2K -7.74% | 22,761 <0.01% of shares | low |
| Feb 1, 2026 | Jonsson Patrik Executive | Other | Common Stock | $1.82M | -2K -3.04% | 55,829 <0.01% of shares | low |
| Feb 1, 2026 | Rau Diogo Executive | Other | Common Stock | $1.74M | -2K -7.13% | 21,797 <0.01% of shares | low |
| Feb 1, 2026 | Hernandez Edgardo Executive | Other | Common Stock | $1.65M | -2K -3.68% | 41,712 <0.01% of shares | low |
| Feb 1, 2026 | Yuffa Ilya Executive | Other | Common Stock | $1.57M | -2K -5.10% | 28,142 <0.01% of shares | low |
| Jan 5, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $1.51M | -1K -0.00% | 92,189,126 9.79% of shares | medium |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $1.45M | -1K -0.00% | 92,171,354 9.79% of shares | medium |
| Feb 9, 2026 | Montarce Lucas Executive | Grant | Common Stock | $1.43M | +1K +9.30% | 16,050 <0.01% of shares | low |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $1.34M | -1K -0.00% | 92,173,748 9.79% of shares | medium |
| Feb 1, 2026 | Dozier Eric Executive | Other | Common Stock | $1.32M | -1K -10.03% | 11,424 <0.01% of shares | low |
| Feb 9, 2026 | Brown Adrienne S Executive | Grant | Common Stock | $1.25M | +1K +32.12% | 4,921 <0.01% of shares | low |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $1.17M | -1K -0.00% | 92,172,676 9.79% of shares | medium |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $1.16M | -1K -0.00% | 92,179,477 9.79% of shares | medium |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $1.01M | -930 -0.00% | 92,178,547 9.79% of shares | medium |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $971.2K | -895 -0.00% | 92,188,231 9.79% of shares | medium |